Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Patents "Differential Display" Genomics Technology

Premium

GAITHERSBURG, Md.--Gene Logic here announced that it was issued a US patent for an enzyme-based genomics technology, "differential display," in which restriction enzymes reveal differences in gene expression among various tissue samples. Gene Logic said that methods based on the approach covered by the patent are more suitable for industrial-scale operations than a differential display method that doesn't require restriction enzymes.

Gene Logic holds an exclusive worldwide license on the patent from the New York Blood Center, whose broad patent covers a variety of methods that involve use of restriction enzymes to generate differential gene-expression patterns.

The new patent broadens protection for Gene Logic's Restriction Enzyme Analysis of Differentially Expressed Sequences display technology, the basis for the company's largest revenue-generating business.

Filed under

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.